TOTAL VOLUME:
$97.5b
24H VOL:
$262,573,226
24H TRANSACTIONS:
951,878,243
OPEN INTEREST:
$2,187,805,448
831,787
Markets across
15,132
events
MATCHED EVENTS:
964
PLATFORM COVERAGE:
5
Polymarket:
45%
VS.
Kalshi:
55%
The Senate Committee on Armed Services will hold a public hearing to receive testimony on the TRICARE Pharmacy program. Witnesses testifying in official capacity will be monitored for specific words or phrases they mention during the live-streamed proceedings.
This event tracks whether any participating witness speaking in an official capacity mentions specific words or phrases during a live-televised or streamed Senate Committee on Armed Services hearing on TRICARE Pharmacy. Resolution is based on the live broadcast or stream, with video as the primary source and official transcripts as secondary verification if consensus cannot be reached. The exact phrase or word must be used, including plural or possessive forms, though grammatical and tense inflections are not required. Tracked terms include: Trump, Biden, TrumpRX, Taxpayer, Fraud, Afford/Affordable/Affordability, Whistleblower, GLP-1/Ozempic, Audit/Audited, Tariff, and AI/Artificial Intelligence. Only statements made in official capacity during the hearing qualify; private conversations, inaudible remarks, or unofficial statements do not count. If the hearing is cancelled or fails to meet qualification criteria, all markets resolve to No and the "Event does not qualify" market resolves to Yes. If postponed with announcement by the following calendar day to a date within 14 days, markets remain open.
Prediction market odds often diverge from traditional analyst forecasts because they incorporate real-money incentives and continuous price discovery. While political analysts and policy experts may publish static reports on expected hearing outcomes, this market updates dynamically as traders respond to breaking news, leaked documents, or shifts in congressional priorities. Analysts typically rely on historical patterns and expert judgment; prediction markets reward accuracy with financial gain, creating a different signal. Comparing the two approaches can reveal where consensus breaks down and where informed traders see contrarian value in specific witness testimony scenarios.
On Kalshi, this market is priced through continuous order-book matching, where buyers and sellers set the odds by placing bids and asks on specific witness statements or hearing outcomes. On Kalshi, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The price of each outcome reflects the probability traders assign to that scenario occurring. As new information surfaces—such as witness confirmations or hearing postponements—the order book adjusts in real time. Tighter spreads indicate higher confidence and liquidity, while wider spreads suggest uncertainty or lower trading activity around that particular outcome.
This market resolves around Jul 30, 2026, once the Senate TRICARE pharmacy hearing concludes and witness testimony becomes part of the public record. The outcome is confirmed when credible public reporting—such as official hearing transcripts, news coverage, or congressional documentation—verifies what was actually said during the proceedings. Traders holding positions on specific statements or themes will see their bets settled based on whether those predictions matched the verified testimony. Resolution typically occurs within days of the hearing, once the evidence is clear and documented.
Key catalysts include official announcements of the final witness list, leaked pre-hearing statements or position papers, and any last-minute schedule changes or cancellations. Media coverage speculating on hearing topics, congressional staff comments, or TRICARE policy developments can shift trader expectations significantly. Unexpected witness withdrawals or surprise additions would also trigger repricing. Additionally, related legislative votes, budget announcements, or pharmacy benefit manager news could influence how traders assess the likely direction and tone of testimony. Each development provides new information that reshapes the probability distribution across possible outcomes.
Follow the signals, not the noise
Get insights on market conviction, notable shifts, and what the data is quietly signaling.